D. Vordos

A. Hoznek, L. Salomon, A. De la taille, 2019, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

External Validation of Extranodal Extension and Lymph Node Density as Predictors of Survival in Node-positive Bladder Cancer after Radical Cystectomy

A. Masson-Lecomte, A. Hoznek, L. Salomon, 2013, Annals of Surgical Oncology.

Predicting tumour location in radical prostatectomy specimens: same‐patient comparisons of 21‐sample versus sextant biopsy

A. Hoznek, L. Salomon, Y. Allory, 2009, BJU international.

Laparoscopic radical prostatectomy after transurethral resection of the prostate: surgical and functional outcomes.

C. Abbou, A. Hoznek, L. Salomon, 2008, Urology.

Laparoscopy and Robotics Laparoscopic Radical Prostatectomy After Transurethral Resection of the Prostate: Surgical and Functional Outcomes

C. Abbou, A. Hoznek, L. Salomon, 2008 .

Robot-assisted laparoscopic sacral colpopexy: initial experience in a high-volume laparoscopic reference center.

C. Abbou, A. Hoznek, L. Salomon, 2010, Journal of endourology.

Docetaxel and zoledronic acid in patients with metastatic hormone‐refractory prostate cancer

A. Hoznek, L. Salomon, D. Chopin, 2004, BJU international.

[Urinary cytology and molecular markers].

L. Bubendorf, D. Vordos, E. Piaton, 2010, Annales de pathologie.

Patient selection and pathological outcomes using currently available active surveillance criteria

A. Hoznek, L. Salomon, Y. Allory, 2013, BJU international.

[Urethro-vesical anastomosis reconstruction using extra-peritoneal robot-assisted laparoscopy for anastomotic stenosis after radical prostatectomy].

A. Hoznek, A. De la taille, D. Vordos, 2021, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Pathological findings and PSA outcomes after laparoscopic radical 1 prostatectomy for high risk prostate cancer

L. Salomon, S. Terry, Y. Allory, 2010 .

Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer

A. De la taille, M. Rouprêt, D. Vordos, 2022, Cancers.

Mid‐term oncological control after laparoscopic radical cystectomy in men: a single‐centre experience

A. Hoznek, L. Salomon, Y. Allory, 2011, BJU international.

Complications and Discharge after Radical Cystectomy for Older Patients with Muscle-Invasive Bladder Cancer: The ELCAPA-27 Cohort Study

D. Vordos, E. Paillaud, T. Cudennec, 2021, Cancers.

Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy.

L. Salomon, S. Terry, Y. Allory, 2014, European urology.

EXTRAPERITONEAL ROBOT-ASSISTED VESICOURETHRAL RECONSTRUCTION TO MANAGE ANASTOMOTIC STRICTURE FOLLOWING RADICAL PROSTATECTOMY.

A. Hoznek, A. De la taille, D. Vordos, 2019, Urology.

International Prostate Symptom Score is a predictive factor of lower urinary tract symptoms after radical prostatectomy

A. Hoznek, L. Salomon, A. Ouzzane, 2015, International journal of urology : official journal of the Japanese Urological Association.

Robotic versus open radical cystectomy throughout the learning phase: insights from a real-life multicenter study

A. Masson-Lecomte, A. De la taille, R. Campi, 2019, World Journal of Urology.

Oncologic outcome after extraperitoneal laparoscopic radical prostatectomy: midterm follow-up of 1115 procedures.

A. Hoznek, L. Salomon, C. Abbou, 2010, European urology.

Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate.

R. Porcher, A. Hoznek, L. Salomon, 2003, Urology.

Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.

H. Wallerand, D. Chopin, J. Thiery, 2004, Carcinogenesis.

Multilayer spectrum of intratumoral heterogeneity in basal bladder cancer

Y. Allory, F. Radvanyi, D. Drubay, 2021, The Journal of pathology.

Pathological findings and prostate‐specific antigen outcomes after laparoscopic radical prostatectomy for high‐risk prostate cancer

L. Salomon, S. Terry, Y. Allory, 2009, BJU international.

A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression

François Radvanyi, Jessica Zucman-Rossi, Jennifer Southgate, 2010, Journal of the National Cancer Institute.

PI3K/AKT pathway activation in bladder carcinogenesis

Y. Allory, F. Radvanyi, J. Calderaro, 2014, International journal of cancer.

Laparoscopic promontory sacral colpopexy: is the posterior, recto-vaginal, mesh mandatory?

C. Abbou, A. Hoznek, P. Antiphon, 2004, European urology.

Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy cores

L. Salomon, Y. Allory, F. Roudot-thoraval, 2015, World Journal of Urology.

Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer.

C. Abbou, A. Hoznek, L. Salomon, 2003, Urology.

Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guérin response of superficial bladder cancer during induction course and maintenance therapy.

J. Patard, F. Saint, D. Chopin, 2003, International journal of cancer.

Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma

Siok Ghee Ler, M. Raida, T. Tan, 2015, Oncotarget.

High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance

L. Salomon, Y. Allory, C. Abbou, 2009, World Journal of Urology.

Urinary continence and erectile function: a prospective evaluation of functional results after radical laparoscopic prostatectomy.

C. Abbou, A. Hoznek, L. Salomon, 2002, European urology.

Radical prostatectomy by the retropubic, perineal and laparoscopic approach: 12 years of experience in one center.

C. Abbou, A. Hoznek, L. Salomon, 2002, European urology.

Introducing a prognostic score for pretherapeutic assessment of seminal vesicle invasion in patients with clinically localized prostate cancer.

R. Porcher, C. Abbou, A. Hoznek, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old

O. Cussenot, G. Pignot, N. Houédé, 2015, Virchows Archiv.

Comparison of early oncologic results of laparoscopic radical prostatectomy by extraperitoneal versus transperitoneal approach.

C. Abbou, A. Hoznek, L. Salomon, 2004, European urology.

Open versus laparoscopic radical prostatectomy: Part II

A. Hoznek, L. Salomon, D. Chopin, 2004, BJU international.

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.

T. H. van der Kwast, S. Culine, A. Broeks, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

CDKN2A homozygous deletion is associated with muscle invasion in FGFR3‐mutated urothelial bladder carcinoma

E. Letouzé, Y. Allory, F. Radvanyi, 2012, The Journal of pathology.

Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol

A. Hoznek, L. Salomon, C. Abbou, 2013, World Journal of Urology.

Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients.

A. Masson-Lecomte, Y. Lotan, S. Boorjian, 2014, European urology.

[Retroperitoneal fibrosis in adults: Main characteristics and relevance of the diagnostic procedures based on a retrospective multicenter study on 77 cases].

D. Vordos, M. Michel, B. Godeau, 2016, La Revue de medecine interne.

Predictive factors for final pathologic ureteral sections on 700 radical cystectomy specimens: Implications for intraoperative frozen section decision-making.

A. Masson-Lecomte, F. Saint, Y. Allory, 2017, Urologic oncology.

Urinary IL‐2 assay for monitoring intravesical bacillus Calmette‐Guérin response of superficial bladder cancer during induction course and maintenance therapy

J. Patard, F. Saint, D. Chopin, 2003 .

Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.

Jean-Jacques Patard, Laurent Salomon, Andras Hoznek, 2007, European urology.

Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinoma

D. Chopin, Y. Allory, F. Radvanyi, 2010, Molecular carcinogenesis.

Retroperitoneal laparoscopic radical nephrectomy: Intermediate oncological results

C. Abbou, A. Hoznek, L. Salomon, 2008, World Journal of Urology.

Laparoscopic radical nephrectomy for T1 renal cancer: the gold standard? A comparison of laparoscopic vs open nephrectomy

C. Abbou, A. Hoznek, L. Salomon, 2004, BJU international.

[Complications of retroperitoneal laparoscopy based on a series of 500 cases].

A. Hoznek, L. Salomon, D. Chopin, 2006, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Comparisons of the perioperative, functional, and oncologic outcomes after robot-assisted versus pure extraperitoneal laparoscopic radical prostatectomy.

A. Hoznek, L. Salomon, C. Abbou, 2014, European urology.

Prostate Cancer Comparisons of the Perioperative , Functional , and Oncologic Outcomes After Robot-Assisted Versus Pure Extraperitoneal Laparoscopic Radical Prostatectomy

A. Hoznek, L. Salomon, C. Abbou, 2014 .

Prediction of recurrence of non muscle‐invasive bladder cancer by means of a protein signature identified by antibody microarray analyses

Y. Allory, F. Radvanyi, M. Sill, 2014, Proteomics.

Robot‐assisted extraperitoneal laparoscopic radical prostatectomy: experience in a high‐volume laparoscopy reference centre

A. Hoznek, L. Salomon, C. Abbou, 2010, BJU international.

Anastomotic stricture after minimally invasive radical prostatectomy: what should be expected from the Van Velthoven single-knot running suture?

A. Hoznek, L. Salomon, C. Abbou, 2012, Journal of endourology.

A switch from GnRH agonist to GnRH antagonist in castration-resistant prostate cancer patients leads to a low response rate on PSA

A. Masson-Lecomte, A. Hoznek, L. Salomon, 2013, World Journal of Urology.

Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life

S. Culine, C. Abbou, A. Hoznek, 2010, Prostate Cancer and Prostatic Diseases.

Impact of positive surgical margins on prostate‐specific antigen failure after radical prostatectomy in adjuvant treatment‐naïve patients

A. Hoznek, L. Salomon, Y. Allory, 2011, BJU international.

[Oncological outcome of radical cystectomy for BCG failure compared to primary invasive disease].

A. Masson-Lecomte, C. Abbou, L. Salomon, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer

Y. Allory, F. Radvanyi, X. Paoletti, 2012, PloS one.

[Photodynamic diagnosis (cystoscopy with hexaminolevulinate) in the surveillance of urothelial lesions managed with conservative treatment].

D. Vordos, 2010, Annales de pathologie.

Analysis of outcomes after radical prostatectomy in patients eligible for active surveillance (PRIAS)

A. Hoznek, L. Salomon, Y. Allory, 2013, BJU international.

Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort

S. Culine, Y. Allory, A. De la taille, 2017, Clinical genitourinary cancer.

Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study.

S. Boorjian, A. Briganti, S. Shariat, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy.

A. Masson-Lecomte, S. Boorjian, A. Vickers, 2015, European urology focus.

Hemostatic radiotherapy for bladder cancer-related hematuria in patients unfit for surgery: is there any impact of fractionation schedule?

D. Vordos, Y. Belkacemi, G. Coraggio, 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy.

L. Salomon, Y. Allory, C. Abbou, 2012, Urology.

Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study

A. Masson-Lecomte, R. Campi, M. Rouprêt, 2018, World Journal of Urology.

The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer.

A. Hoznek, L. Salomon, Y. Allory, 2010, The Journal of urology.

Location, extent, and multifocality of positive surgical margins for biochemical recurrence prediction after radical prostatectomy

A. Hoznek, L. Salomon, Y. Allory, 2014, World Journal of Urology.

Extended Biopsy Protocol Decreases Prostate Cancer Incidence and Risk of Aggressive Disease on Repeated Biopsies Compared with Initial Standard Procedure

L. Salomon, Y. Allory, C. Abbou, 2010, Urologia Internationalis.

Prognostic Consequences of the Location of Positive Surgical Margins in Organ-Confined Prostate Cancer

C. Abbou, A. Hoznek, L. Salomon, 2003, Urologia Internationalis.

Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?

A. Hoznek, L. Salomon, Y. Allory, 2010, The Journal of urology.

Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.

J. Patard, A. Hoznek, L. Salomon, 2009, European urology.

Long-term impact of positive surgical margins on biochemical recurrence after radical prostatectomy: Ten years of follow-up

Laurent Salomon, Andras Hoznek, A. Hoznek, 2014, Scandinavian journal of urology.

Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen

M. Rubin, A. Hoznek, L. Salomon, 2006, World Journal of Urology.

Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.

A. Hoznek, L. Salomon, Y. Allory, 2009, The Journal of urology.

Invasion of bladder neck after radical prostatectomy: one definition for different outcomes

C. Abbou, A. Hoznek, L. Salomon, 2008, Prostate Cancer and Prostatic Diseases.

Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand in FGFR3-mutated Tumors.

Y. Allory, F. Radvanyi, I. Bernard-Pierrot, 2023, European urology.

63 THE ROLE OF BIOPSY CORE NUMBER IN SELECTING PROSTATE CANCER PATIENTS FOR ACTIVE SURVEILLANCE

C. Abbou, A. Hoznek, L. Salomon, 2010 .

[Urachus pathology: infected urachal cyst].

A. Luciani, A. Rahmouni, D. Vordos, 2011, Journal de radiologie.

[Impact of neoadjuvant chemotherapy on the peri-operative morbidity of radical cystectomy for muscle invasive bladder cancer].

A. Masson-Lecomte, S. Culine, P. Meria, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy : results on toxicity , side effects and quality-of-life

A. Hoznek, Y. Allory, D. Vordos, 2010 .

outcomes after radical prostatectomy in men eligible for active surveillance{does the risk of misclassication vary according to biopsy criteria?

A. Hoznek, L. Salomon, Y. Allory, 2010 .

Pathological findings and PSA outcomes after radical prostatectomy in men eligible for active surveillance: does the risk of misclassification vary according to the different biopsy criteria?

L. Salomon, Y. Allory, C. Abbou, 2010 .

Pathological findings and PSA outcomes after radical prostatectomy in men eligible for active surveillance: does the risk of misclassification vary according to the different biopsy criteria?

L. Salomon, Y. Allory, C. Abbou, 2010 .

Long-term impact of positive surgical margins on biochemical recurrence after radical prostatectomy: Ten years of follow-up

A. Hoznek, L. Salomon, Y. Allory, 2014, Scandinavian journal of urology.

[Pathological findings after radical prostatectomy in men eligible for active surveillance (French trial SURACAP): is the misclassification rate acceptable?].

A. Hoznek, Y. Allory, C. Abbou, 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.